Evidence map›Paper›PMID 41701471›Full record

ArticleApplied health economics and health policy2026

Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening.

Max Lelie, Bo VandenBulcke, Nick Verhaeghe, Lieven Annemans, Steven Simoens, Koen Putman

Abstract read
PubMed Publisher
In one paragraph

Article in Applied health economics and health policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Max LelieVUB Health Campus, Laarbeeklaan 103, 1090, Jette, Brussels Capital Region, Belgium. max.lelie@vub.be.ORCID 0000-0002-0561-9879
Bo VandenBulckeVUB Health Campus, Laarbeeklaan 103, 1090, Jette, Brussels Capital Region, Belgium.
Nick VerhaegheVUB Health Campus, Laarbeeklaan 103, 1090, Jette, Brussels Capital Region, Belgium.
Lieven AnnemansGhent University, Ghent, Belgium.
Steven SimoensKU Leuven, Leuven, Belgium.
Koen PutmanVUB Health Campus, Laarbeeklaan 103, 1090, Jette, Brussels Capital Region, Belgium.

Funding

Vlaamse Overheid VLOV132
6 · The paper itself

Abstract

objectiveWe present a novel dynamic risk-stratified breast cancer screening Markov model designed to maintain robust and epidemiologically consistent cancer prevalences, regardless of the number or composition of risk-stratification groups. This approach addresses a common limitation in existing models, where altering risk-group definitions or proportions can unintentionally distort overall incidence rates. By overcoming this constraint, the method lowers barriers to developing interactive, flexible and policy-relevant models that can be shared directly with decision makers. The paper serves as both a methodological contribution and a practical guide for implementation.

methodsOur approach combines conditional transition probabilities with pre-stratified 'at-risk' states within a conventional Markov cohort framework. Lifetime risk is determined at the structural level, while the timing of onset is governed by age-specific conditional probabilities. These components are derived directly from Flemish cancer registry data, enabling close alignment with the target population and facilitating epidemiological validation.

resultsWe validate the model against empirical breast cancer incidence data from Flanders, comparing predicted outcomes across age bands and cancer stages. The method consistently reproduces observed incidence patterns without additional calibration, maintaining stability when risk group definitions or sizes are varied.

conclusionsCombining pre-stratified 'at-risk' states with conditional transition probabilities offers a simple yet powerful means of achieving epidemiological consistency in both risk-stratified and non-stratified cancer screening models. The method is data driven, transparent, and adaptable to different cancers or screening contexts, making it especially valuable for interactive models intended for use by policymakers.

Indexed as

Breast NeoplasmsEarly Detection of CancerAgedBelgiumFemaleHumansIncidenceMarkov ChainsMiddle AgedRisk Assessment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.